Clinical Research Directory

Observational Prospective Study of Immune Checkpoint Inhibitors for Solid Neoplasms

Sponsor: Fudan University

Summary

This prospective, multicenter observational study included all patients with solid neoplasms who received treatment with immune checkpoint inhibitors (ICIs) in clinical practice, regardless of tumor type, tumor stage, type of immunotherapy, or treatment lines. This study aimed to assess the use, effectiveness, and safety of ICIs for solid neoplasms in real-world populations, which can provide insights into clinical decisions associated with the use of ICIs for the treatment of cancer patients in the real-world setting.

Official title: Multicenter Observational Prospective Study of Immune Checkpoint Inhibitors in Patients With Solid Neoplasms

Key Details

Conditions

Locations (1)